TrialLiver international : official journal of the International Association for the Study of the Liver2018

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin.

Jordan J Feld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.